Prof. Mike Carrier publishes article in Harvard Health Policy Review

Prof. Mike Carrier published “A Simple Solution to the Problem of ‘Product Hopping’” in the Harvard Health Policy Review. The piece explains why legislation addressing product hopping, in which brand-name drug companies switch from one version of a drug to another just to keep the generic off the market, is the best option to address … Continue reading Prof. Mike Carrier publishes article in Harvard Health Policy Review

Prof. Michael Carrier testifies before House Energy & Commerce Committee

Prof. Carrier testified before the House Energy & Commerce Committee in support of legislation that would lower drug prices by targeting “pay-for-delay” settlements and citizen petitions. This was the second time he testified in Congress in the past week. https://energycommerce.house.gov/committee-activity/hearings/hearing-on-negotiating-a-better-deal-legislation-to-lower-the-cost-of